Oncodesign Company

Oncodesign develops anticancer therapies for the treatment of patients with cancer.
Technology: Precision Medicine
Industry: Early and Preclinical Drug Development
Headquarters: Dijon, Bourgogne, France
Founded Date: 1995-01-01
Employees Number: 101-250
Funding Status: IPO
Investors Number: 3
Total Funding: 29400000
Estimated Revenue: $1M to $10M
Last Funding Date: 2009-08-26
Last Funding Type: Undisclosed

Visit Website
Register and Claim Ownership